Technical Analysis for EYES - Second Sight Medical Products, Inc.

Grade Last Price % Change Price Change
D 6.98 -5.16% -0.38
EYES closed down 5.16 percent on Monday, April 19, 2021, on 5 percent of normal volume. The stock fell below its 50 day moving average, damaging its intermediate-term outlook by crossing under that important trendline. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Strong Up Down Down
Historical EYES trend table...

Date Alert Name Type % Chg
Fell Below 50 DMA Bearish 0.00%
Stochastic Reached Oversold Weakness 0.00%
Wide Bands Range Expansion 0.00%
Down 3 Days in a Row Weakness 0.00%
Down 4 Days in a Row Weakness 0.00%
Down 5 Days in a Row Weakness 0.00%
Oversold Stochastic Weakness 0.00%
MACD Bearish Centerline Cross Bearish -5.16%
1,2,3 Pullback Bullish Bullish Swing Setup -5.16%
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup -5.16%
Older End-of-Day Signals for EYES ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
Down 5% about 14 hours ago
60 Minute Opening Range Breakdown about 14 hours ago
Fell Below 50 DMA about 14 hours ago
50 DMA Support about 14 hours ago
Fell Below Previous Day's Low about 14 hours ago
View Earlier Intraday Alerts

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Second Sight Medical Products, Inc. Description

Second Sight Medical Products, Inc. was founded in 1998 with a mission to restore vision to the blind. Today, Second Sight’s Argus II retinal prosthesis provides functional vision to patients blinded by outer retinal degenerations such as retinitis pigmentosa. The company’s innovative technology is the only retinal prosthesis approved by the United States FDA and the first device to receive a CE mark in Europe. The company’s transformative prosthetic device allows blind individuals to gain greater independence in their daily lives. Second Sight believes that its award winning technology will serve as a platform to treat nearly all forms of blindness and could be extended to other neurostimulation applications beyond vision restoration. The Argus II system is currently available in the US and Europe and the company is actively pursuing additional geographic markets. With next generation products under development, the company plans to continue developing, manufacturing and marketing its innovative visual prostethics around the world. Second Sight’s US Headquarters are in Sylmar, California. European Headquarters are in Lausanne, Switzerland.


Classification

Sector: Healthcare
Industry: Medical Devices
Keywords: Medicine Biotechnology Emerging Technologies Medical Devices FDA Medical Products Retina Blindness Vision Retinitis Biomedical Engineering Retinitis Pigmentosa Generation Products Neurostimulation Neuroprosthetics

Is EYES a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 20.0
52 Week Low 0.6906
Average Volume 29,253,041
200-Day Moving Average 2.66
50-Day Moving Average 7.12
20-Day Moving Average 8.65
10-Day Moving Average 8.28
Average True Range 1.45
ADX 29.37
+DI 30.93
-DI 23.27
Chandelier Exit (Long, 3 ATRs ) 13.60
Chandelier Exit (Short, 3 ATRs ) 11.12
Upper Bollinger Band 11.14
Lower Bollinger Band 6.17
Percent B (%b) 0.16
BandWidth 57.50
MACD Line -0.15
MACD Signal Line 0.21
MACD Histogram -0.3597
Fundamentals Value
Market Cap 161.37 Million
Num Shares 23.1 Million
EPS -0.39
Price-to-Earnings (P/E) Ratio -17.85
Price-to-Sales 17.56
Price-to-Book 63.98
PEG Ratio 0.00
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 8.11
Resistance 3 (R3) 8.16 7.84 7.92
Resistance 2 (R2) 7.84 7.55 7.81 7.85
Resistance 1 (R1) 7.41 7.38 7.25 7.36 7.79
Pivot Point 7.09 7.09 7.01 7.06 7.09
Support 1 (S1) 6.66 6.80 6.50 6.61 6.17
Support 2 (S2) 6.34 6.63 6.31 6.11
Support 3 (S3) 5.91 6.34 6.04
Support 4 (S4) 5.86